Ascendia

  MARKET NEWS

 

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification With the European Directorate for the Quality of Medicines & Healthcare
Abata Therapeutics Receives FDA Fast Track Designation for Progressive Multiple Sclerosis Treatment
Emergex Receives Patent Protection for First-in-Class Influenza A Vaccines With Potential to Provide Long-Term T Cell Immunity
Ingenza Announces Partnership With Cellugy to Investigate the Potential of Biofabricated Cellulose
PCI Pharma Services’ Bedford, NH Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
SGS Introduces New Specialized Bioanalytical Testing Services in North America
Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent
Cumulus Oncology & leadXpro Achieve Critical Milestone
ST Pharm & Quantoom Biosciences Announce First Supply Agreement of SmartCap Under Extended Collaboration to Advance RNA Manufacturing
Pharma CMO M&A Activity Shifts Focus to Scaling in 2023

  EXPERT CONTENT & RESOURCES

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

ALBA SUCCESS CASE

Container Selection for a Highly Sensitive Drug Product: A Success Story

For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

This article explains the key changes that pharmaceutical companies and CMOs engaged in manufacturing and fill-finish need to consider, as well as what AbbVie Contract Manufacturing (AbbVie CMO) is doing to ensure its global operations and aseptic fill-finish sites are in compliance with the revised regulations….

  FEATURED EDITORIAL

  COMPANY PROFILE

Nanjing Well Pharmaceutical Group Co., Ltd., a high-tech enterprise from China specializing in R&D, manufacturing, and supplying pharmaceutical excipients and APIs. Our factory is located in Nanjing National New Materials Technology Park. We are currently one of the largest suppliers of pharmaceutical excipients for solid, semi-solid, and liquid preparations in China, with annual sales of more than 10,000 tons and sales of more than 40 million US dollars. We maintain long-term and stable cooperation with more than 1,000 pharmaceutical companies at home and abroad, such as Johnson & Johnson, GSK, Novartis, Bayer, and other multinational pharmaceutical companies. Click here for more.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

By: Jasmine Musakhanian, Senior Scientific Director, Gattefossé

INTRODUCTION

Mono and diglycerides, also known as partial glycerides, are versatile lipid excipients that play a pivotal role in the realization of drug products and nutraceuticals. Some well-known excipients in this category are …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 4 – API Synthesis
September 11 – Bioavailability